Funded Biotechnology Startups in Lausanne
Among the 24 most recent biotech rounds in Lausanne (sorted by round date descending), the largest disclosed amount is MindMaze’s $105M on 2022-02-17, whic…
Among the 24 most recent biotech rounds in Lausanne (sorted by round date descending), the largest disclosed amount is MindMaze’s $105M on 2022-02-17, which dwarfs the next-largest disclosed rounds in the $65M band (ReproNovo $65M on 2025-05-21; HAYA Therapeutics $65M on 2025-05-08; Timeline $65M on 2024-01-17) and stands well above other disclosed entries such as AC Immune’s $4M on 2026-06-11 or Calico Biosystems’ $170K on 2024-06-25. The list also shows a tight clustering in time: 11 rounds fall between 2024-02-09 and 2025-05-21, including two $65M rounds just two weeks apart in May 2025.
Stage and disclosure patterns are also skewed. “Series Unknown” appears in many rows (including Isospec Analytics $490K on 2026-06-23; AC Immune $4M on 2026-06-11; SamanTree Medical $24M on 2026-01-27; and multiple other entries), while undisclosed amounts occur twice on 2024-02-09 (GenKnowme and Roumai Medical). The disclosed amounts range from a low of $30K for SensArs on 2024-09-06 to MindMaze’s $105M, spanning several orders of magnitude.
Most recent rounds
24 shownRelated listings
Frequently asked
What’s the largest disclosed round on this Lausanne biotech list, and how does it compare to the rest of the disclosed amounts?
MindMaze’s $105M round (2022-02-17, “Venture - Series Unknown”) is the only disclosed entry above $100M, and it is substantially larger than the next-largest disclosed $65M rounds for ReproNovo (2025-05-21) and HAYA Therapeutics (2025-05-08), plus Timeline’s $65M (2024-01-17).
Are there any clear date clusters among the most recent 24 rounds?
Yes. 11 of the 24 rounds land between 2024-02-09 (GenKnowme and Roumai Medical, undisclosed) and 2025-05-21 (ReproNovo $65M), including a concentrated pair of $65M rounds in May 2025 (HAYA Therapeutics $65M on 2025-05-08 and ReproNovo $65M on 2025-05-21).
How should “disclosure” be handled here: do “Series Unknown” and “undisclosed” amounts meaningfully affect analysis?
Two entries list an undisclosed amount (GenKnowme and Roumai Medical on 2024-02-09), so they can’t be used for largest/smallest comparisons. Separately, many rounds are labeled “Series Unknown” (for example Isospec Analytics $490K on 2026-06-23, AC Immune $4M on 2026-06-11, and SamanTree Medical $24M on 2026-01-27), which makes stage-based comparisons less precise than amount-based comparisons.
What stage mix dominates these rounds, based on the labels shown?
Seed appears repeatedly (e.g., Beech Biotech $500K on 2026-04-02; Alithea Genomics $4M on 2026-03-04; Emovo Care $110K on 2025-11-06; Hemostod $5M on 2025-10-05), while very large disclosed rounds are mostly concentrated in a few labeled entries such as Series A/Series D (ReproNovo and HAYA Therapeutics at $65M as Series A; Timeline $65M as Series D; Lunaphore $33M as Series D).
What are the most notable outliers by amount on this list?
SensArs’ $30K (2024-09-06, Seed) is the smallest disclosed amount, while MindMaze’s $105M (2022-02-17) is the largest disclosed amount, creating a wide spread. Mid-range disclosed amounts cluster around tens of millions for several companies (e.g., Lunaphore $33M on 2023-03-23; Nagi Bioscience $14M on 2023-09-28), but the $105M round sits well apart from that group.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.